Berenberg Bank assumed coverage on shares of Stericycle (NASDAQ:SRCL) in a report released on Thursday morning, The Fly reports. The firm issued a buy rating and a $76.00 price objective on the business services provider’s stock.

Other research analysts have also issued research reports about the company. Royal Bank of Canada restated a buy rating on shares of Stericycle in a research report on Thursday, June 18th. Bank of America raised their price target on Stericycle from $44.00 to $52.00 and gave the company an underperform rating in a report on Monday, August 17th. Raymond James reaffirmed a hold rating on shares of Stericycle in a research note on Tuesday, October 6th. Barrington Research lowered shares of Stericycle to a hold rating in a report on Tuesday, July 28th. Finally, BidaskClub downgraded shares of Stericycle from a buy rating to a hold rating in a research note on Thursday, October 8th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of Hold and an average target price of $66.11.

NASDAQ SRCL opened at $66.24 on Thursday. Stericycle has a 12 month low of $38.45 and a 12 month high of $67.94. The company has a current ratio of 0.90, a quick ratio of 0.90 and a debt-to-equity ratio of 0.87. The stock has a market cap of $6.06 billion, a PE ratio of -19.89, a P/E/G ratio of 4.38 and a beta of 1.22. The stock’s 50 day moving average is $63.39 and its 200 day moving average is $57.02.

Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, August 6th. The business services provider reported $0.46 EPS for the quarter, topping the consensus estimate of $0.25 by $0.21. Stericycle had a negative net margin of 10.05% and a positive return on equity of 9.73%. The firm had revenue of $598.20 million for the quarter, compared to the consensus estimate of $589.27 million. During the same quarter in the previous year, the firm earned $0.56 earnings per share. The company’s quarterly revenue was down 29.3% compared to the same quarter last year. On average, analysts forecast that Stericycle will post 2.14 EPS for the current fiscal year.

In other news, EVP Daniel Ginnetti sold 6,238 shares of the firm’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $64.80, for a total value of $404,222.40. Following the completion of the sale, the executive vice president now owns 7,364 shares in the company, valued at approximately $477,187.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.30% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Clarkston Capital Partners LLC raised its holdings in shares of Stericycle by 2.1% in the second quarter. Clarkston Capital Partners LLC now owns 4,172,234 shares of the business services provider’s stock worth $233,562,000 after buying an additional 86,587 shares during the period. State Street Corp increased its stake in Stericycle by 1.7% in the first quarter. State Street Corp now owns 2,137,554 shares of the business services provider’s stock worth $103,842,000 after purchasing an additional 35,582 shares during the period. Saddle Point Management L.P. increased its stake in Stericycle by 0.9% in the first quarter. Saddle Point Management L.P. now owns 1,600,642 shares of the business services provider’s stock worth $77,759,000 after purchasing an additional 14,402 shares during the period. Frontier Capital Management Co. LLC lifted its position in shares of Stericycle by 4.9% during the second quarter. Frontier Capital Management Co. LLC now owns 1,367,907 shares of the business services provider’s stock worth $76,575,000 after purchasing an additional 63,384 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of Stericycle by 3.8% during the first quarter. Geode Capital Management LLC now owns 1,101,258 shares of the business services provider’s stock valued at $53,499,000 after purchasing an additional 40,813 shares during the period.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States, Europe, and internationally. It operates through three segments: North America RWCS; International RWCS; and Domestic Communication and Related Services.

See Also: Is it Safe to Invest in Commodities?

The Fly

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.